Webinar: From Traditional Knowledge to Efficacy Driven Modern Day CBD


The Center for Dermal Research Rutgers University, New Jersey Speaker: Dr. Manpreet Randhawa, Director Research & Innovation, Sytheon Ltd. Cannabidiol (CBD) has become immensely popular and has been portrayed to offer an interesting combination of popular holistic medicine and a natural answer to synthetic drugs. CBD is a phytocannabinoid and non-psychoactive isomer of tetrahydrocannabinol (THC) […]

Sytheon has published a study in the Journal of Investigative Dermatology

Sytheon has published a study in the Journal of Investigative Dermatology, profiling mechanistic details of Isosorbide Di-(Linoleate/Oleate) & supporting its effectiveness for the treatment of xerotic pruritic skin The breakdown of the epidermal barrier and consequent loss of skin hydration is a feature of skin aging and eczematous dermatitis. Few treatments, however, resolve these underlying processes to […]

Sytheon Obtains a New US Patent on Synoxyl® AZ (Acetyl Zingerone)

Sytheon inventors have discovered that Synoxyl® AZ (Acetyl Zingerone) functions not only as a highly effective and unique non-sacrificial antioxidant, anti-inflammatory, and anti-aging ingredient, but that it also helps manage skin pigmentation by modulating three distinct non-tyrosinase pathways. Assigned to Sytheon, U.​S. Patent 10,828,241 discloses, “Skin lightening compositions and methods.” This invention relates to skin […]

Sytheon Publishes a Detailed Mechanistic Study on Synastol® TC

Publication: WS Swindell, K Bojanowski and RK Chaudhuri, A standardized Terminalia chebula fruit extract alters the expression of genes associated with skin architecture and barrier formation, European J Dermatology, 2020, doi: 10.1684/ejd.2020.3882 Abstract: Genome-wide expression responses to a standardized tannin-enriched extract, called Synastol® TC, were investigated in three-dimensional reconstituted human skin tissues through microarray studies. […]

Webinar: How to de-stress your skin?

Join us on October, 6th at 10 AM (EDT) Asyntra® CBD-Alt is a carefully crafted ingredient that works alone or in synergy with CBD/hemp oil to enhance its benefits, in part by decreasing the loss of anandamide, the “bliss molecule,” in skin. This maintains skin’s homeostasis even under stress for a relaxed appearance and radiant […]

Sytenol® A, the only natural Bakuchiol Webinar

Join us on September, 24th at 10 AM (EDT) As a brand, it can be difficult to choose the right active ingredient in a world driven by digital buzz and natural bogus claims. Sytheon has been working for more than 10 years to offer you a defined active ingredient with unmatched quality: Sytenol®A with 99.9% […]

Just when you thought you selected the right skin brightener & even toner!

Under the recent FDA stated CARES act Hydroquinone is not considered as GRAS and has also been classified as Drug Category II (For more information, visit the website at: https://www.jdsupra.com/legalnews/congress-enacts-otc-monograph-reform-96907/ )  Sytheon introduced Synovea® HR (INCI: Hexylresorcinol) as a safer and efficacious alternative to Hydroquinone in 2006. Synovea® HR is the optimal tool for addressing hyperpigmentation […]

Sytenol® A Bakuchiol Receives the 2020 Ringier Technology Innovation Award

Sytheon Ltd. is proud to announce that Sytenol® A Bakuchiol has been selected as the “2020 Effective Ingredients Winner” by Ringier Trade Media, China, and HAPPI China Magazine as part of their 2020 Ringier Technology Innovation Awards for the Personal Care Industry. The Ringier Technology Innovation Awards are the most prestigious and influential industrial awards […]

COVID-19 Pandemic – Business Operations & Safety

Dear Friends, Customers and Partners, As the COVID-19 pandemic evolves, our thoughts are with you during these turbulent times. We are monitoring updates from WHO, CDC and the NJ Government for guidance on best practices to ensure a safe environment for our employees, customers, partners and fellow citizens. We do believe there is a role […]